Table 3.
Significant genes in TADA-R analysis of autism control trios
| Gene | BF_LoF | BF_D-Mis | p_value | FDR | Annotation |
|---|---|---|---|---|---|
| RAMP3 | 2.95 | 1.01E + 03 | 4.00E−04 | 1 | Unknown |
| ANKRD55 | 1.86E + 02 | 1.24 | 5.00E−04 | 1 | Unknown |
| BCAR3 | 1.46E + 01 | 2.92 | 7.00E−04 | 1 | Unknown |
| KLK9 | 5.95E−02 | 2.04E + 02 | 9.00E−04 | 1 | Unknown |
| PCCA | 1.04E−01 | 1.91E + 06 | 0.001 | 1 | Unknown |
| TELO2 | 8.37E−02 | 2.96E + 03 | 0.001 | 1 | Unknown |
| FAM126A | 1.23E−01 | 1.05E + 04 | 0.0011 | 1 | Unknown |
| SYTL3 | 1.03E + 01 | 6.14 | 0.0012 | 1 | Unknown |
| DOCK10 | 4.05E−02 | 1.27E + 04 | 0.0012 | 1 | Unknown |
| MAPK8 | 2.63E−01 | 4.42E + 01 | 0.0012 | 1 | Unknown |
TADA-R analysis was performed on 1,789 autism control trios. Bayes factor values are computed separately for LoF and D-Mis variants (shown as BF_LoF and BF_D-Mis). We annotate significant genes on where they are known human CHD genes.